Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05186311 · ClinicalTrials.gov registry record
BD MiniDraw™ Capillary System Clinical Equivalence Study
A clinical trial of Healthy and Acute Disease, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 262
- Enrollment target
- 1
- Study location
NCT05186311 is a study of Healthy and Acute Disease that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 262 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05186311, a study of Healthy and Acute Disease, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
This study designed to evaluate the safety and effectiveness of a newly developed sample collection device. Participants will be enrolled and samples will be collected by representative future users of the device. Comparator venous and conventional capillary tubes will be collected by skilled healthcare professionals with phlebotomy experience. Samples will be tested and average differences between the investigational device compared to a marketed comparator will be evaluated. Visual observations will be captured and device safety will be assessed.
Conditions Studied
Interventions
- DEVICE Capillary Blood Collection System
Study Locations (1)
Texas
- Babson Diagnostics - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2022-10-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05186311
The ClinicalTrials.gov registry entry for NCT05186311 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Capillary Blood Collection System is the first listed.
NCT05186311 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05186311 about?
NCT05186311 is a clinical study titled "BD MiniDraw™ Capillary System Clinical Equivalence Study". This study designed to evaluate the safety and effectiveness of a newly developed sample collection device. Participants will be enrolled and samples will be collected by representative future users of the device. Comparator venous and conventional capillary tubes will be collected by skilled health...
What is the current status of trial NCT05186311?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2022-04-22. Estimated completion is 2022-10-24.
What conditions does trial NCT05186311 study?
This clinical trial studies the following conditions: Healthy, Acute Disease, Sample Collection, Disease, Chronic.
What interventions are being tested in trial NCT05186311?
The interventions under investigation include: Capillary Blood Collection System (DEVICE).
Who is sponsoring clinical trial NCT05186311?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05186311 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.